References
- IDSA Task Force. Infectious Diseases Society of America (IDSA) position statement: why IDSA did not endorse the surviving sepsis campaign guidelines. Clin Infect Dis. 2018;66(10):1631–1635.
- Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. JAMA. 2017;318(13):1241–1249.
- Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810.
- Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):775–787.
- Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):762–774.
- Kalil AC, Gilbert DN, Winslow DL, et al. Reply to al-hasan and justo. Clin Infect Dis. 2018. [Epub ahead of print].
- Murri R, Taccari F, Palazzolo C, et al. IDSA did not endorse the surviving sepsis campaign guidelines. Clin L Infect Dis. 2018;66(11):1815–1816.
- Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–1554.
- Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–1377.
- Seymour CW, Gesten F, Prescott HC, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376(23):2235–2244.
- Herrán-Monge, R, Muriel-Bombín A, García-García MM, et al. Epidemiology and changes in mortality of sepsis after the implementation of surviving sepsis campaign guidelines. J Intensive Care Med. 2017;885066617711882. [Epub ahead of print].
- Yealy DM, Yealy DM, Kellum JA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683–1693.
- Peake SL, Peake SL, Delaney A, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496–1506.
- Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301–1311.
- Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–1596.
- Marik PE, Linde-Zwirble WT, Bittner EA, et al. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database. Intensive Care Med. 2017;43(5):625–632.
- FDA News Release. FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis. Food and Drug Administration. 2017.
- Huang DT, Yealy DM, Filbin MR, et al. Procalcitonin-guided use of antibiotics for lower respiratory tract infection. N Engl J Med. 2018.
- Jenkins I. Evidence-based sepsis therapy: a hospitalist perspective. J Hosp Med. 2006;1(5):285–295.
- Khurana A, Vinayek N. Evidence-based sepsis therapy: a hospitalist perspective. J Hosp Med. 2007;2(2):117. author reply 118.